Treat-and-Extend Regimen for Wet AMD: New Hope for Patients
Battling Blindness with Less Injections
Wet age-related macular degeneration (AMD), a leading cause of blindness, has traditionally been treated with monthly anti-VEGF injections into the eye. However, a new treatment strategy known as "treat and extend" offers hope for reducing the number of injections while still maintaining vision.
Reduce Injection Frequency, Improve Outcomes
The treat-and-extend approach involves starting patients on monthly injections and then gradually increasing the time between injections as the disease stabilizes. Studies have shown that this method can reduce injection frequency by up to half, while maintaining or even improving vision outcomes.
Benefits Beyond Vision
In addition to reducing the burden of frequent injections, the treat-and-extend strategy may also have other benefits. It can decrease the risk of complications from injections, such as infection or retinal detachment. Additionally, it can improve patient satisfaction and quality of life by eliminating the need for frequent hospital visits.
Conclusion
The treat-and-extend regimen is a promising new approach to managing wet AMD. By reducing the number of injections, it can alleviate the burden on patients and improve their overall health and well-being. As research continues, this innovative strategy has the potential to revolutionize the treatment of wet AMD and protect the vision of millions worldwide. 
Researchgate
American Academy Of Ophthalmology
Comments